MSD Animal Health offers products for multiple species and diseases. AQUAVAC® Strep Sa1 is for active immunization to protect against S. aglactiae serotype Ia & Serotype III infections in tilapia.
AQUAVAC® Strep Sa1 is a bivalent oil-adjuvant vaccine that protects against both S. aglactiae serotype Ia & serotype III infections in tilapia. Used properly, this product should actively reduce mortalities and the spread of Streptococcosis.
Causative Agent: Streptococcus agalactiae serotype Ia & Streptococcus agalactiae serotype III
Indications: AQUAVAC® Strep Sa1 is for the active immunization of tilapia to reduce mortality due to Streptococcosis caused by Streptococcus agalactiae Biotype I (serotype Ia and III).
Administration: Prior to vaccination, food should be withheld for at least one day, tools should be sterile, and fish should be under anesthesia. Stress should be avoided before and after the vaccination. Shake the vaccine before administering 0.05 ml into the intra-peritoneal cavity, halfway between the base and the tip of the pelvic fins.
With AQUAVAC® Strep Sa1, the duration of immunity against S. agalactiae serotype Ia & serotype III infections has been demonstrated to last at least 12 weeks after vaccination. This means that greater numbers of healthier fish can be produced and sold, boosting productivity and maximizing returns.
To download this factsheet you must be logged in to Aquavac. Login now
Download the AQUAVAC® Product Detailer for more information on performance and quality of AQUAVAC® Strep Sa1. This whitepaper includes further material on species, target diseases and administration concerning this reliable vaccine.